HomeInsightsStock Comparison

Mono Pharmacare Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Mono Pharmacare Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: Jul 19, 2025

Key Highlights

  • The Latest Trading Price of Mono Pharmacare Ltd is ₹ 24 as of 18 Jul 15:30.
  • The P/E Ratio of Mono Pharmacare Ltd changed from 32 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 38.1 on March 2025 . This represents a CAGR of 9.18% over 6 years.
  • The Market Cap of Mono Pharmacare Ltd changed from ₹ 77.92 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 416392 crore on March 2025 . This represents a CAGR of 30.45% over 6 years.
  • The revenue of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 89.64 % on March 2025 . This represents a CAGR of 20.09% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mono Pharmacare Ltd

  • Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
  • Mono Chemist' through Partnership Deed dated May 06, 1994.
  • The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
  • The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Mono Pharmacare Ltd News Hub

News

Mono Pharmacare to conduct board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

13 May 2025 16:38

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 April 2...

Read more

05 Apr 2025 14:35

News

Mono Pharmacare to hold board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 2 April 20...

Read more

29 Mar 2025 09:47

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

03 Feb 2025 10:50

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 January...

Read more

04 Jan 2025 10:27

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

07 Nov 2024 15:32

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is qu...

Read more

15 Jul 2025 13:05

News

Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp

The drug is indicated for the treatment of alopecia areata ' a condition in which the immu...

Read more

15 Jul 2025 15:41

News

Sun Pharmaceutical Industries launches LEQSELVI' (deuruxolitinib) 8 mg tablets in United States

Sun Pharmaceutical Industries announced LEQSELVI' (deuruxolitinib) 8 mg tablets is now ava...

Read more

14 Jul 2025 16:48

News

Sun Pharma settles litigation related to LEQSELVI' with Incyte

 Sun Pharmaceutical Industries  announced that further to its intimation dated 10 April 20...

Read more

14 Jul 2025 16:53

News

Sun Pharmaceuticals Industries to table results

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

12 Jul 2025 10:08

News

Sun Pharma updates on US FDA inspection

Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing ...

Read more

14 Jun 2025 12:11

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mono Pharmacare Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mono Pharmacare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Mono Pharmacare Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Mono Pharmacare Ltd is 42 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 406,267 Cr

What are the key factors driving the stock performance of Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd?

As of July 19, 2025, the Mono Pharmacare Ltd stock price is INR ₹24.0. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1693.25.

How do dividend payouts of Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Mono Pharmacare Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions